close 73% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 73% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

LLY

1,058.87

+1.65%↑

JNJ

203.92

+0.27%↑

ABBV

236.16

+2.85%↑

UNH

319.35

+2.41%↑

AZN

91.01

+2.64%↑

Strona główna・Stock List・Karyopharm Therapeutics Inc
Search

Karyopharm Therapeutics Inc

Closed

SectorHealthcare

5.75 0.88

Strong Buy

Price update 21 lis 2025, 20:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

5.47

Max

5.92

Key metrics

By Trading Economics

Income

4.1M

-33M

Sales

6.1M

44M

EPS

-3.82

Profit margin

-75.213

Employees

279

EBITDA

1.8M

-23M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+134.41% upside

Market Stats

By TradingEconomics

Market Cap

-3.5M

99M

Previous open

4.87

Previous close

5.75

News Sentiment

By Acuity

50%

50%

171 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

5.9501 / 7.66 Support & Resistance

Karyopharm Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

21 lis 2025, 22:42 UTC

Market Talk

Fitch Raises Cyprus's Outlook to Positive From Stable -- Market Talk

DJ

Read

21 lis 2025, 21:50 UTC

Market Talk
Earnings

Tech, Media & Telecom Roundup: Market Talk

DJ

Read

21 lis 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Read

21 lis 2025, 21:47 UTC

Market Talk

Mexico's 3Q GDP Prompts Growth Downgrades -- Market Talk

DJ

Read

21 lis 2025, 21:43 UTC

Market Talk

U.S. Crude Production Defies Low Prices, Rig Count -- Market Talk

DJ

Read

21 lis 2025, 20:18 UTC

Market Talk

Oil Futures Fall on U.S. Push for Russia-Ukraine Peace -- Market Talk

DJ

Read

21 lis 2025, 20:14 UTC

Market Talk

U.S. Natural Gas Gains As Traders Focus on Weather -- Market Talk

DJ

Read

21 lis 2025, 19:48 UTC

Market Talk

Precious Metals Fall for the Week -- Market Talk

DJ

Read

21 lis 2025, 19:44 UTC

Earnings

Deere Earnings, Inflation Data, Black Friday: What to Watch in the Next Week -- WSJ

DJ

Read

21 lis 2025, 19:37 UTC

Market Talk

Dollar Stalls as Stocks and Bonds Rise -- Market Talk

DJ

Read

21 lis 2025, 19:27 UTC

Market Talk
Earnings

Global Equities Roundup: Market Talk

DJ

Read

21 lis 2025, 19:27 UTC

Market Talk
Earnings

Intuit Seen With Underappreciated Credit Karma Momentum -- Market Talk

DJ

Read

21 lis 2025, 19:20 UTC

Market Talk

European Natural Gas Premium Versus U.S. Shrinks -- Market Talk

DJ

Read

21 lis 2025, 18:44 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Palo Alto-Chronosphere Synergies Questioned Despite M&A Record -- Market Talk

DJ

Read

21 lis 2025, 18:37 UTC

Market Talk

U.S. Oil Rig Count Rises By 2 to 419 -- Market Talk

DJ

Read

21 lis 2025, 18:34 UTC

Market Talk
Earnings

Intuit Seen Outperforming on Conservative Guidance -- Market Talk

DJ

Read

21 lis 2025, 18:28 UTC

Earnings

Veeva Systems Earnings Beat Expectations. Why the Stock Is On Pace for Its Largest Drop Since 2023. -- Barrons.com

DJ

Read

21 lis 2025, 18:03 UTC

Market Talk

Mexico's Inflation Seen Up Slightly in Early November -- Market Talk

DJ

Read

21 lis 2025, 17:24 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Read

21 lis 2025, 17:24 UTC

Market Talk

Intuit Seen on Path to Increase Growth -- Market Talk

DJ

Read

21 lis 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

DJ

Read

21 lis 2025, 17:05 UTC

Market Talk

Lowe's Getting Boost From Busy Small to Medium Pro Customer -- Market Talk

DJ

Read

21 lis 2025, 16:56 UTC

Market Talk

Gold Recovers as Investors Boost Rate-Cut Bets -- Market Talk

DJ

Read

21 lis 2025, 16:47 UTC

Market Talk

European Gas-Price Forecast to Decline Further on Expanding LNG Supply -- Market Talk

DJ

Read

21 lis 2025, 16:35 UTC

Acquisitions, Mergers, Takeovers

What Stocks Al Gore's Investment Firm Bought and Sold This Quarter -- Barrons.com

DJ

Read

21 lis 2025, 16:09 UTC

Earnings

Veeva Systems Earnings Beat Expectations. Why the Stock Is On Pace for Its Largest Drop Since 2023. -- Barrons.com

DJ

Read

21 lis 2025, 15:59 UTC

Market Talk

Canadian Consumers Tapping the Brakes, Still See Resilient -- Market Talk

DJ

Read

21 lis 2025, 15:59 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Read

21 lis 2025, 15:23 UTC

Market Talk

Bank of Canada Not Expected to Be Swayed by Canadian Retail Trade Data -- Market Talk

DJ

Read

21 lis 2025, 15:17 UTC

Market Talk

Canadian Consumer Spending Softening, But Could Be Worse -- Market Talk

DJ

Read

Peer Comparison

Price change

Karyopharm Therapeutics Inc Forecast

Price Target

By TipRanks

134.41% upside

12 Months Forecast

Average 13.83 USD  134.41%

High 21 USD

Low 6 USD

Based on 6 Wall Street analysts offering 12 month price targets forKaryopharm Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

5

Buy

1

Hold

0

Sell

Based on 6 analysts giving stock ratings to Karyopharm Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

5.9501 / 7.66Support & Resistance

Short Term

Bullish Evidence

Recent bullish events outweigh bearish events.

Intermediate Term

Strong Bearish Evidence

All events are bearish.

Long Term

No Evidence

There are no events.

Sentiment

By Acuity

171 / 374 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

1,058.87

↑ +1.65%

JNJ

Johnson and Johnson

203.92

↑ +0.27%

ABBV

AbbVie Inc

236.16

↑ +2.85%

UNH

UnitedHealth Group Inc

319.35

↑ +2.41%

AZN

AstraZeneca PLC ADR

91.01

↑ +2.64%
help-icon Live chat